Finance

Lists
Why is OKUR up 4.78%?
Dive Deeper
OKUR:NASDAQ
Onkure Therapeutics Inc
$2.41
+4.78%
(+0.11) 1D
$2.43
+0.83% (+0.020)
After hours
Closed: Oct 9, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OKUR...
Open
$2.29
High
$2.42
Low
$2.23
Mkt. cap
97.60M
Avg. vol.
311.73K
Volume
609.37K
52-wk high
$5.38
52-wk low
$2.13
EPS
-$3.50
Beta
0.12
Shares outstanding
40.50M
No. of employees
45
Open
$2.29
High
$2.42
Low
$2.23
Mkt. cap
97.60M
Avg. vol.
311.73K
Volume
609.37K
52-wk high
$5.38
52-wk low
$2.13
EPS
-$3.50
Beta
0.12
Shares outstanding
40.50M
No. of employees
45
News stories
From web sources and news partners
About Onkure Therapeutics Inc
CEO-
Employees45
Founded2011
HeadquartersBoulder, Colorado, United States
SectorBiotechnology
Websiteonkuretherapeutics.com
Analyst ratings
Based on 4 analysts giving stock ratings to OKUR in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for OKUR in the last 3 months.
Highest
Current $2.41
$21.00 (+771.37%)
Average
$17.00 (+605.39%)
Lowest
$14.00 (+480.91%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Biegler
Oppenheimer
Buy
Reiterated
$14.00
+480.9%
08/14/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
$14.00
+480.9%
08/14/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
$16.00
+563.9%
08/05/2026
Boris Peaker
JonesTrading
Hold
Maintained
-
-
08/05/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
$21.00
+771.4%
07/20/2026
Soumit Roy
JonesTrading
Buy
Maintained
$17.00
+605.4%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11.92M
10.72M
11.71M
12.61M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.59M
3.40M
3.91M
4.29M
Operating expense
15.50M
14.12M
15.62M
16.90M
Total operating expenses
15.50M
14.12M
15.62M
16.90M
Operating income
-15.50M
-14.12M
-15.62M
-16.90M
Other non operating income
-
-
-
-
EBT including unusual items
-14.70M
-13.50M
-15.16M
-15.35M
EBT excluding unusual items
-14.70M
-13.50M
-15.16M
-15.35M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14.70M
-13.50M
-15.16M
-15.35M
Net profit margin
-
-
-
-
Earnings per share
-1.09
-0.99
-1.11
-0.31
Interest and investment income
804.00K
628.00K
458.00K
1.55M
Interest expense
-2.00K
-6.00K
-
-
Net interest expenses
802.00K
622.00K
458.00K
1.55M
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.39M
-14.02M
-15.51M
-16.81M
Gain or loss from assets sale
2.00K
4.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps